These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7694540)

  • 1. Modulation of the estradiol-17 beta mitogenic effect on human breast cancer MCF-7 cells by serum albumin in defined medium.
    Germain P; Harbrioux G
    Anticancer Res; 1993; 13(5A):1581-5. PubMed ID: 7694540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium.
    Furuya Y; Kohno N; Fujiwara Y; Saitoh Y
    Cancer Res; 1989 Dec; 49(23):6670-4. PubMed ID: 2819716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
    Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
    Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-stimulation of postconfluent cell accumulation and foci formation of human MCF-7 breast cancer cells.
    Gierthy JF; Lincoln DW; Roth KE; Bowser SS; Bennett JA; Bradley L; Dickerman HW
    J Cell Biochem; 1991 Feb; 45(2):177-87. PubMed ID: 2055945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of estrogen growth response in MCF-7 cells.
    Wiese TE; Kral LG; Dennis KE; Butler WB; Brooks SC
    In Vitro Cell Dev Biol; 1992; 28A(9-10):595-602. PubMed ID: 1429362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture.
    Biswas R; Vonderhaar BK
    Cancer Res; 1987 Jul; 47(13):3509-14. PubMed ID: 3581086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and responsiveness to estrogen of human endometrial cancer cells under serum-free culture conditions.
    Holinka CF; Anzai Y; Hata H; Kimmel N; Kuramoto H; Gurpide E
    Cancer Res; 1989 Jun; 49(12):3297-301. PubMed ID: 2720684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
    Lewis JS; Osipo C; Meeke K; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitogenic stimulation of human breast cancer cells in a growth factor-defined medium: synergistic action of insulin and estrogen.
    van der Burg B; Rutteman GR; Blankenstein MA; de Laat SW; van Zoelen EJ
    J Cell Physiol; 1988 Jan; 134(1):101-8. PubMed ID: 3275677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth control of human mammary cancer cells (MCF-7 cells) in culture: effect of estradiol and growth factors in serum-containing medium.
    Aakvaag A; Utaaker E; Thorsen T; Lea OA; Lahooti H
    Cancer Res; 1990 Dec; 50(24):7806-10. PubMed ID: 2253223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth medium for the evaluation of antiestrogenic compounds in MCF-7 cell culture.
    Jain PT; Pento JT
    Methods Find Exp Clin Pharmacol; 1991 Nov; 13(9):595-8. PubMed ID: 1787766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of culture conditions on the estrogenic cell growth stimulation of human breast cancer cells.
    Ruedl C; Cappelletti V; Coradini D; Granata G; Di Fronzo G
    J Steroid Biochem Mol Biol; 1990 Oct; 37(2):195-200. PubMed ID: 2268550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the dextran-coated charcoal assay for estradiol receptor in breast cancer preparations.
    Shafie S; Brooks SC
    J Lab Clin Med; 1979 Nov; 94(5):784-98. PubMed ID: 501205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum albumin as a modulator on growth of the human breast cancer cell line, MCF-7.
    Laursen I; Briand P; Lykkesfeldt AE
    Anticancer Res; 1990; 10(2A):343-51. PubMed ID: 2346307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalization and biological effects of serum albumin in the breast cancer MCF-7 and MDA-MB 231 cells.
    Germain P; Metezeau P; Hellio R; Habrioux G
    Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1119-29. PubMed ID: 8747093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitogenic effect of estradiol on MCF-7 human breast cancer cells can be modulated by serum.
    Najid A; Nicolas A; Tixier M; Habrioux G
    Exp Cell Biol; 1989; 57(3):139-45. PubMed ID: 2776961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum.
    Welshons WV; Grady LH; Engler KS; Judy BM
    Breast Cancer Res Treat; 1992; 23(1-2):97-104. PubMed ID: 1446058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.